Document:

Document

APOLLO ENDOSURGERY 2020 CORPORATE BONUS PLAN
PURPOSE OF THE PLAN
The Apollo Endosurgery Bonus Plan (the “Plan”) is designed to reward eligible employees for their contributions toward the successful accomplishment of specific financial and strategic business objectives, and individual performance.
PERFORMANCE
Bonus amounts are determined based on both corporate performance and individual performance in relation to pre-established objectives.
Corporate Performance
Corporate performance will be measured based on financial objectives approved by the board of directors.
Individual Performance
Individual performance will be measured based on the achievement of objectives and goals prepared by each participant and his or her manager and documented on an Individual Performance Plan. Objectives and goals are established at the beginning of each Plan Year, but may be modified throughout the Plan Year as necessary or appropriate, with management approval. Objectives and goals will be expressed as specific, quantifiable measures of performance in relation to key operating decisions for the participant’s department. While individual performance is normally based on the manager’s rating, the individual manager rating may be subject to executive override.
BONUS POOL CALCULATION AND ALLOCATIONS
The Plan will have two separately funded pools – a Corporate pool (the “Corporate Component”) and Individual pool (the “Individual Component”).
The bonus pools will have the following levels of achievement defined below:
•Individual Threshold – is solely determined at the discretion of the Board upon their end of year review of the overall Company’s financial condition and operating performance.
•Corporate Component Threshold – minimum Company financial performance required before any corporate component pool will be funded.
•Target – financial performance required before the corporate component is eligible to be funded at 100%.
The key financial or operational targets of the Company form the corporate component, which is reviewed and set annually. Exceptions to this and modifications to this Bonus Plan can be made at any time at the board’s sole discretion.
At Target, corporate performance component of the bonus is anticipated to fund at 100% and individual’s manager rating (subject to adjustment) will determine the individual performance component. The two together form the individual’s final bonus amount.
A multiplier will be applied for performance between the Corporate Threshold and Target to determine the percentage of the bonus pool that will be funded, as well as performance that is above Target. The minimum funding for The Corporate Component bonus pool is 40% and there is no pre-established maximum funding limit for over achieving target.
Corporate Component for 2020
Three performance metrics for the corporate component for 2020 are as follows:
•50% weighting.  Target achievement of 2020 Endo product revenues
•30% weighting.  Target achievement of 2020 Endo gross margin
•20% weighting.  Target achievement of 2020 operating expenses
BONUS POOL ADJUSTMENTS AND DIFFERENTIATION BY DEPARTMENT
The bonus pool may be allocated to the business units/function level by the Company’s Chief Executive Officer based on such matters as he may determine to be appropriate, including but not limited to operating income results vs. budget, performance in relation to pre-established objectives and other financial results. For example, a business unit or department that exceeds its goals may receive a greater share of the total bonus pool than a business unit that under performs.

At the end of the Plan Year, the Company’s Chief Executive Officer may recommend adjustments to the bonus pool to the board of directors after consideration of key operating results. When calculating corporate performance for purposes of this Plan, the board of directors has the discretion to consider such matters as it determines to be appropriate, including any or all of the following:
•Extraordinary financial or corporate transactions that may occur during the plan year
•Effects of accounting changes
•Expenses for productivity initiatives
•Other non-operating items
•Integration activities or expense
•Performance in relation to pre-established objectives
•Any other items of significant income or expense which are determined to be appropriate adjustments
Individual Bonus Calculation
Target bonus awards will be expressed as a percentage of the employee’s eligible earnings for the Plan Year. Eligible earnings are defined as regular earnings paid during the year, holiday, vacation, and personal leave time. The target percentages will vary by position level. A participant’s actual bonus award may vary above or below the targeted level based on corporate performance, the overall performance of his or her business unit relative to the overall performance of the Company, and the participant’s performance in relation to his or her pre-determined individual objectives.

									
	Position Level
	Corporate Component Percentage
	Individual Component Percentage

	CEO	100%	Board Discretion
	C-Level and VPs	80%	20%
	Directors, GMs, and Sr. Managers,	50%	50%
	Managers and Professional Level (Exempt)	25%	75%
	Hourly	0%	100%Exhibit
4.1

 

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “1933 ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR OTHERWISE
DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE 1933 ACT, OR AN OPINION OF COUNSEL,
SATISFACTORY TO THE ISSUER HEREOF, TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE 1933 ACT AS SOME OTHER EXEMPTION
FROM THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND APPLICABLE LAWS IS AVAILABLE.

 

	Warrant
    No.	CS-____	Number
    of Shares: 500,000
	Warrant
    Date:	February
    28, 2020	 

 

SRAX,
INC..

WARRANT

FOR
THE PURCHASE OF

CLASS
A COMMON STOCK

 

1.
Issuance. For value received, the receipt of which is hereby acknowledged by SRAX, Inc.., a Delaware corporation (the
“Company”), BRF Finance Co., LLC, or registered and permitted assigns (the
“Holder”), is hereby granted the right to purchase, at any time or times on or after February 28,
2020 (the “Initial Exercisability Date”) until 5:00 P.M., Pacific Standard Time on October 31,
2022 (the “Expiration Date”), Five Hundred Thousand (500,000) fully paid and
nonassessable shares of the Company’s Class A Common Stock, par value US$0.001 per share (the “Common
Stock”), at an exercise price of US$[●] per share (the “Exercise
Price”).

 

This
Warrant is being issued by the Company in connection with, but for the avoidance of doubt is detached from, the Company’s
execution of a Term Loan Note in the aggregate principal amount of $5,000,000.00 to the Warrant Holder (the “Term Loan
Note”) pursuant to that certain Term Loan and Security Agreement dated as of February 28, 2020 (the “Term Loan
and Security Agreement”; capitalized terms not otherwise defined herein shall have the respective meanings set forth
in the Term Loan and Security Agreement or the Term Loan Note).

 

2.
Procedure for Exercise.

 

a.
At any time after the Initial Exercisability Date, and upon surrender of this Warrant with the annexed Notice of Exercise Form
duly executed, together with payment in cash of the Exercise Price (a “Cash Exercise”) (provided that
the Exercise Price shall be deemed delivered in connection with the delivery of a Notice of Exercise Form in connection with a
Cashless Exercise (as defined below), if applicable) for the shares of Common Stock purchased (the “Warrant Shares”),
the Holder shall be entitled to receive a certificate or certificates for the shares of Common Stock so purchased. This Warrant
may be exercised in whole or in part. On any such partial exercise, provided the Holder has surrendered the original Warrant,
the Company will issue and deliver to the order of the Holder a new Warrant of like tenor, in the name of the Holder, for the
whole number of shares of Common Stock for which such Warrant may still be exercised. No fractional shares of Common Stock are
to be issued upon the exercise of this Warrant, but rather the number of shares of Common Stock to be issued shall be rounded
up to the nearest whole number.

 

b.
If at any time after the six (6) month anniversary of the issuance date of the this Warrant, there is no effective registration
statement registering, or the prospectus contained therein is not available for the issuance and resale of the Warrant Shares,
then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which
the Holder shall be entitled to receive a number of Warrant Shares computed using the following formula (a “Cashless
Exercise”):

 

    	 

    	 

    

 

X
= Y (A-B)

A

Where:

 

	 	 	X=
    the number of shares of Common Stock to be issued to the Holder.
	 	 	Y=
    the number of shares of Common Stock to be purchased under this Warrant.
	 	 	A=
    Fair Market Value per share of one share of Common Stock as of the date of exercise.
	 	 	B=
    the Exercise Price (as adjusted).

 

For
purposes of this Warrant, “Fair Market Value” means, as of any date, the value of Common Stock determined
as follows:

 

(i)
If the Common Stock is listed on any established stock exchange or a national market system, including without limitation any
division or subdivision of the Nasdaq Stock Market (each a “Principal Market”), its Fair Market Value
will be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such exchange or system
on the date of exercise, as reported in The Wall Street Journal or such other source as the Board of Directors of the Company
deem reliable;

 

(ii)
If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, including without
limitation quotation through the over the counter bulletin board (“OTCQB®”) quotation service administered
by the Financial Industry Regulatory Authority (“FINRA”)(each a “Quotation Market”),
the Fair Market Value of a Share will be the closing price for the Common Stock on the date of exercise, as reported in The Wall
Street Journal or such other source as the Board of Directors of the Company deem reliable; or

 

(iii)
In the absence of an established market for the Common Stock, the Fair Market Value will be determined in good faith by the Company’s
Board of Directors.

 

For
the sake of clarity and in an abundance of caution, no Cashless Exercise of this Warrant shall be able to be affected by the Holder
at any time and to the extent that the shares of Common Stock issuable upon exercise of such Warrant (or portion thereof) are
registered in a Registration Statement declared effective by the Securities and Exchange Commission.

 

c.
Notwithstanding anything to the contrary contained in this Warrant, this Warrant shall not be exercisable by the Holder hereof
to the extent (but only to the extent) that the Holder or any of its affiliates would beneficially own in excess of 9.99% (the
“Maximum Percentage”) of the Common Stock. To the extent the above limitation applies, the determination
of whether this Warrant shall be exercisable (vis-à-vis other convertible, exercisable or exchangeable securities owned
by the Holder or any of its affiliates) and of which such securities shall be exercisable (as among all such securities owned
by the Holder) shall, subject to such Maximum Percentage limitation, be determined on the basis of the first submission to the
Company for conversion, exercise or exchange (as the case may be). No prior inability to exercise this Warrant pursuant to this
paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination
of exercisability. For the purposes of this paragraph, beneficial ownership and all determinations and calculations (including,
without limitation, with respect to calculations of percentage ownership) shall be determined in accordance with Section 13(d)
of the Exchange Act (as defined in the Term Loan and Security Agreement) and the rules and regulations promulgated thereunder.
The provisions of this paragraph shall be implemented in a manner otherwise than in strict conformity with the terms of this paragraph
to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Maximum Percentage
beneficial ownership limitation herein contained or to make changes or supplements necessary or desirable to properly give effect
to such Maximum Percentage limitation. The limitations contained in this paragraph shall apply to a successor Holder of this Warrant.

 

    	 	2 	 

    	 

    

 

3.
Reservation and Listing of Shares; Piggyback Registration.

 

a.
The Company hereby agrees that at all times during the term of this Warrant there shall be reserved for issuance upon exercise
of this Warrant such number of shares of Common Stock as shall be required for issuance upon exercise hereof. Any shares issuable
upon exercise of this Warrant will be duly and validly issued, fully paid and free of all liens and charges and not subject to
any preemptive rights. The Company, at its expense, shall cause such securities to be included in or listed on all markets or
stock exchanges in or on which the Common Stock is included or listed not later than the date on which the Common Stock is first
included or listed on any such market or exchange and will thereafter maintain such inclusion or listing of all shares of Common
Stock from time to time issuable upon exercise of this Warrant.

 

b.
The Company covenants and agrees with the Holder that if, at any time prior to the Expiration Date, it proposes to file a registration
statement with respect to any class of equity or equity-related security (other than in connection with an offering to the Company’s
employees or in connection with an acquisition, merger or similar transaction) under the Act in a primary registration on behalf
of the Company and/or in a secondary registration on behalf of holders of such securities and the registration form to be used
may be used for the resale of the Warrant Shares, the Company will either include the Warrant Shares in such registration statement
or give prompt written notice to the Holder of its intention to file a registration statement and will offer to include the Warrant
Shares in such registration statement,

 

4.
Mutilation or Loss of Warrant. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction
or mutilation of this Warrant, and (in the case of loss, theft or destruction) receipt of reasonably satisfactory indemnification,
and (in the case of mutilation) upon surrender and cancellation of this Warrant, the Company will execute and deliver a new warrant
of like tenor and date and any such lost, stolen, destroyed or mutilated Warrant shall thereupon become void.

 

5.
No Rights as Shareholder. The Holder shall not, by virtue hereof, be entitled to any rights of a shareholder of the Company,
either at law or in equity, and the rights of the Holder are limited to those expressed in this Warrant and are not enforceable
against the Company except to the extent set forth herein.

 

6.
Effect of Certain Transactions

 

6.1
Adjustments for Stock Splits, Stock Dividends Etc. If the number of outstanding shares of Common Stock of the Company are
increased or decreased by a stock split, reverse stock split, stock dividend, stock combination, recapitalization or the like,
the Exercise Price and the number of shares purchasable pursuant to this Warrant shall be adjusted proportionately so that the
ratio of (i) the aggregate number of shares purchasable by exercise of this Warrant to (ii) the total number of shares outstanding
immediately following such stock split, reverse stock split, stock dividend, stock combination, recapitalization or the like shall
remain unchanged, and the aggregate purchase price of shares issuable pursuant to this Warrant shall remain unchanged.

 

6.2
Expiration Upon Certain Transactions. If at any time the Company plans to sell all or substantially all of its assets or
engage in a merger or consolidation of the Company in which the Company will not survive and in which holders of the Common Stock
will receive consideration at or above the Exercise Price, as adjusted (other than a merger or consolidation with or into a wholly-
or partially-owned subsidiary of the Company), the Company will give the Holder of this Warrant advance written notice.

 

    	 	3 	 

    	 

    

 

6.3
Adjustments for Reorganization, Mergers, Consolidations or Sales of Assets. If at any time there is a capital reorganization
of the Common Stock (other than a recapitalization, combination, or the like provided for elsewhere in this Section 6) or merger
or consolidation of the Company with another corporation (other than one covered by Section 6.2), or the sale of all or substantially
all of the Company’s properties and assets to any other person, then, as a part of such reorganization, merger, consolidation
or sale, provision shall be made so that the Holder shall thereafter be entitled to receive upon exercise of this Warrant (and
only to the extent this Warrant is exercised), the number of shares of stock or other securities or property of the Company, or
of the successor corporation resulting from such merger or consolidation or sale, to which a holder of Common Stock, or other
securities, deliverable upon the exercise of this Warrant would otherwise have been entitled on such capital reorganization, merger,
consolidation or sale. In any such case, appropriate adjustments shall be made in the application of the provisions of this Section
6 (including adjustment of the Exercise Price then in effect and number of Warrant Shares purchasable upon exercise of this Warrant)
which shall be applicable after such events.

 

(a)
Reserved.

 

6.4
Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to Sections 6.1 through
6.3, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and
furnish to each Holder of this Warrant a certificate setting forth such adjustment or readjustment and showing in detail the facts
upon which such adjustment or readjustment is based. The Company shall promptly furnish or cause to be furnished to such Holder
a like certificate setting forth: (i) such adjustments and readjustments; and (ii) the number of shares and the amount, if any,
of other property which at the time would be received upon the exercise of the Warrant.

 

6.5
Certain Events. If any event occurs as to which the other provisions of Sections 6.1 through 6.3 are not strictly applicable
but the lack of any adjustment would not fairly protect the purchase rights of the Holder under this Warrant in accordance with
the basic intent and principles of such provisions, or if strictly applicable would not fairly protect the purchase rights of
the Holder under this Warrant in accordance with the basic intent and principles of such provisions, then the Company’s
Board of Directors will, in good faith, make an appropriate adjustment to protect the rights of the Holder; provided, that
no such adjustment pursuant to Sections 6.1 through 6.3 will increase the Exercise Price or decrease the number of Warrant Shares
except as expressly set forth in Sections 6.1 through 6.3.

 

7.
Transfer to Comply with the Securities Act. This Warrant has not been registered under the Securities Act of 1933, as amended,
(the “Securities Act”) and has been issued to the Holder for investment and not with a view to the distribution
of either this Warrant or the Warrant Shares. Neither this Warrant nor any of the Warrant Shares or any other security issued
or upon exercise of this Warrant may be sold, transferred, pledged or hypothecated in the absence of an effective Registration
Statement under the Act relating to such security or an opinion of counsel satisfactory to the Company that registration is not
required under the Act and that such transfer further complies with applicable securities laws and transfer restrictions. Each
certificate for this Warrant, the Warrant Shares and any other security issued or issuable upon exercise of this Warrant shall
contain a legend in form and substance satisfactory to counsel for the Company, setting forth the restrictions on transfer contained
in this Section.

 

    	 	4 	 

    	 

    

 

8.
No Stock Rights and Legend.

 

No
holder of this Warrant, as such, shall be entitled to vote or be deemed the holder of any other securities of the Company that
may at any time be issuable on the exercise hereof, nor shall anything contained herein be construed to confer upon the holder
of this Warrant, as such, the rights of a stockholder of the Company or the right to vote for the election of directors or upon
any matter submitted to stockholders at any meeting thereof, or give or withhold consent to any corporate action or to receive
notice of meetings or other actions affecting stockholders (except as provided herein), or to receive dividends or subscription
rights or otherwise (except as provide herein).

 

Each
certificate for Warrant Shares initially issued upon the exercise of this Warrant, and each certificate for Warrant Shares issued
to any subsequent transferee of any such certificate, shall be stamped or otherwise imprinted with a legend in substantially the
following form:

 

“THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR
OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE
SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION EXISTS AND THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE HOLDER
OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE OFFERED,
SOLD, PLEDGED, ASSIGNED OR TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR
APPLICABLE STATE SECURITIES LAWS.”

 

9.
Notices. Any notice or other communication required or permitted hereunder shall be in writing and shall be delivered personally
or sent by certified, registered or express mail, postage pre-paid electronic mail or facsimile. Any such notice shall be deemed
given (1) when delivered, in person or by courier or other delivery service, (2) when sent, if sent by facsimile to the party’s
fax number below and mechanically confirmed, (3) when sent by email on the same day if during the work day or the subsequent day
if sent after or (4) three days after deposit in the United States mail, postage prepaid, certified, return receipt requested,
as follows:

 

If
to the Company, to:

 

SRAX,
Inc.

456
Seaton Street

Los
Angeles, CA 90013

Attn:
Christopher Miglino

Telephone:

Email:
Chris@Srax.com

 

With
a copy (which shall not constitute notice) to:

 

Silvestre
Law Group, P.C.

31200
Via Colinas., Suite 200

Westlake
Village, CA 91362

Attn:
Raul Silvestre, Esq.

Telephone:
(818) 597-7552

Email:
rsilvestre@silvestrelaw.com

 

If
to the Holder, to his, her or its address appearing on the Company’ records.

 

    	 	5 	 

    	 

    

 

Any
party may designate another address or person for receipt of notices hereunder by notice given to the other parties in accordance
with this Section.

 

10.
Supplements and Amendments; Whole Agreement. This Warrant may be amended or supplemented only by an instrument in writing
signed by the Company and the Holder hereof. This Warrant contains the full understanding of the parties hereto with respect to
the subject matter hereof, and there are no representations, warranties, agreements or understandings other than expressly contained
herein.

 

11.
Governing Law. This Warrant shall be deemed to be a contract made under the laws of the State of New York and for all purposes
shall be governed by and construed in accordance with the laws of such State applicable to contracts to be made and performed
entirely within such State. Any action brought by either party against the other concerning the transactions contemplated by this
Warrant shall be brought only in the state courts of New York or in the federal courts located in New York County, New York. The
parties to this Warrant hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and
shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. Each party hereby
irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in connection
with this Warrant by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any other manner permitted by law.

 

12.
Severability. If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable
by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed
amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such
provision shall not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues
to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited
nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations
or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the
parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)
with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable
provision(s).

 

13.
Counterparts. This Warrant may be executed in any number of counterparts and each of such counterparts shall for all purposes
be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

14.
Descriptive Headings. Descriptive headings of the several Sections of this Warrant are inserted for convenience only and
shall not control or affect the meaning or construction of any of the provisions hereof.

 

15.
Benefits of this Warrant. Nothing in this Warrant shall be construed to confer upon any person other than the Company and
Holder any legal or equitable right, remedy or claim under this Warrant and this Warrant shall be for the sole and exclusive benefit
of the Company and Holder.

 

16.
Loss of Warrant. Upon receipt by the Company of evidence of the loss, theft, destruction or mutilation of this Warrant,
and (in the case of loss, theft or destruction) of indemnity or security reasonably satisfactory to the Company, and upon surrender
and cancellation of this Warrant, if mutilated, the Company shall execute and deliver a new Warrant of like tenor and date.

 

17.
Assignability. This Warrant or any part hereof may only be hereafter assigned by the Holder to an affiliate thereof executing
documents reasonably required by the Company as described in Section 7 hereof. Any such assignment shall be binding on the Company
and shall inure to the benefit of any such assignee.

 

[Signature
Pages Follow]

 

    	 	6 	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Warrant as of the Warrant Date set forth above.

 

	 	SRAX,
    INC.
	 	 
	 	By:	 
	 	Name:	Michael
    Malone
	 	Title:	Chief
    Financial Officer

 

	 	HOLDER:
	 	 	 
	 	
	 	 	 
	 	By:
    	                                            
	 	Name:
    	 
	 	Title:
    	 

 

    	 	7 	 

    	 

    

 

NOTICE
OF EXERCISE OF WARRANT

 

TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

WARRANT
TO PURCHASE COMMON STOCK

 

SRAX,
INC.

 

The
undersigned holder hereby exercises the right to purchase _________________ of the shares of Class A Common Stock (“Warrant
Shares”) of SRAX, a Delaware corporation (the “Company”), evidenced by Warrant No. _______ (the “Warrant”).
Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

 

1.
Form of Exercise Price. The Holder intends that payment of the Exercise Price shall be made as:

 

	 	____________	a “Cash Exercise” with respect to
_________________ Warrant Shares; and/or

 

	 	____________	a “Cashless Exercise” with respect
to _______________ Warrant Shares (if and only to the extent available pursuant to the terms of the Warrant).

 

In
the event that the Holder has elected a Cashless Exercise with respect to some or all of the Warrant Shares to be issued pursuant
hereto, the Holder hereby represents and warrants that the Fair Market Value of the Common Stock in connection with such Cashless
Exercise is _____________.

 

2.
Payment of Exercise Price. In the event that the Holder has elected a Cash Exercise with respect to some or all of the
Warrant Shares to be issued pursuant hereto, the Holder shall pay the aggregate Exercise Price in the sum of $___________________
to the Company in accordance with the terms of the Warrant.

 

3.
Maximum Percentage Representation. Notwithstanding anything to the contrary contained herein, this Notice of Exercise shall
constitute a representation by the Holder of the Warrant submitting this Notice of Exercise that, after giving effect to the exercise
provided for in this Notice of Exercise, such Holder (together with its affiliates) will not have beneficial ownership (together
with the beneficial ownership of such person’s affiliates) of a number of shares of Common Stock which exceeds the Maximum
Percentage (as defined in the Warrant) of the total outstanding shares of Common Stock of the Company as determined pursuant to
the provisions of Section 2(c) of the Warrant.

 

4.
Delivery of Warrant Shares. The Company shall deliver to Holder, or its designee or agent as specified below, __________
Warrant Shares in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:

 

[  ] Check here if requesting delivery as a certificate to the following name and to the following address:

 

	 	Issue
    to:	 
	 	 	 
	 	 	 

 

[  ] Check here if requesting delivery by Deposit/Withdrawal at Custodian as follows:

 

	 	DTC
    Participant:	 
	 	 	 
	 	DTC
    Number:	 
	 	 	 
	 	Account
    Number:	 

 

	Date: _______________ __, ______	 
		 	 
	 	 
	Name
of Registered Holder	 
	 	 	 
	By:
    	                    	 
	Name:	 	 
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}]]